American Century Companies’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $390K | Sell |
113,760
-2,904
| -2% | -$9.96K | ﹤0.01% | 2598 |
|
|
2025
Q1 | $260K | Sell |
116,664
-223
| -0.2% | -$497 | ﹤0.01% | 2694 |
|
|
2024
Q4 | $342K | Sell |
116,887
-239
| -0.2% | -$700 | ﹤0.01% | 2639 |
|
|
2024
Q3 | $305K | Sell |
117,126
-90
| -0.1% | -$234 | ﹤0.01% | 2642 |
|
|
2024
Q2 | $347K | Sell |
117,216
-108
| -0.1% | -$320 | ﹤0.01% | 2570 |
|
|
2024
Q1 | $531K | Sell |
117,324
-231
| -0.2% | -$1.05K | ﹤0.01% | 2426 |
|
|
2023
Q4 | $671K | Sell |
117,555
-837,068
| -88% | -$4.78M | ﹤0.01% | 2244 |
|
|
2023
Q3 | $4.39M | Sell |
954,623
-158,293
| -14% | -$728K | ﹤0.01% | 1377 |
|
|
2023
Q2 | $7.19M | Sell |
1,112,916
-179,676
| -14% | -$1.16M | 0.01% | 1178 |
|
|
2023
Q1 | $9.59M | Buy |
1,292,592
+4,335
| +0.3% | +$32.2K | 0.01% | 1034 |
|
|
2022
Q4 | $13.1M | Buy |
1,288,257
+712,995
| +124% | +$7.22M | 0.01% | 875 |
|
|
2022
Q3 | $5.69M | Buy |
+575,262
| New | +$5.69M | 0.01% | 1069 |
|